|
" Medical stigmata : "
Kirk A. Johnson.
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
891478
|
| Main Entry
|
:
|
Johnson, Kirk A.
|
| Title & Author
|
:
|
Medical stigmata : : race, medicine, and the pursuit of theological liberation /\ Kirk A. Johnson.
|
| Publication Statement
|
:
|
Singapore :: Palgrave Macmillan,, [2019]
|
| Page. NO
|
:
|
1 online resource
|
| ISBN
|
:
|
9789811329920
|
|
|
:
|
: 9811329923
|
|
|
:
|
9789811329913
|
|
|
:
|
9811329915
|
| Bibliographies/Indexes
|
:
|
Includes bibliographical references.
|
| Contents
|
:
|
Introduction -- Race-based medicine -- Maleficence toward the minority patient -- Research, race and profit -- Black theology and reconciliation -- Conclusion.
|
| Abstract
|
:
|
This book observes the idea of race as a false representation for the cause of disease. Race-based medicine, an emerging field in pharmacology, aims to create a specialty market based on racial groups. Within this market, the drug BiDil set a precedent in this area of medicine targeting African Americans as its first racial group. Consequently, selecting African Americans as a "starter group" led to ethical questions regarding the motive behind race-based medicine within the context of the larger treatment of blacks in American medical history. This book therefore links medicine and American eugenics, examines race-based medicines influence on the perception of the black body, traces the influence of BiDils approval on the resurgence of race-based medicine, and assesses the black churchs response to race-based medicine using black liberation theology as a means to social justice.
|
| Subject
|
:
|
Pharmaceutical ethics.
|
| Subject
|
:
|
Race-- Social aspects.
|
| Subject
|
:
|
Continental Population Groups.
|
| Subject
|
:
|
Ethics, Pharmacy.
|
| Subject
|
:
|
BUSINESS ECONOMICS-- Business Ethics.
|
| Subject
|
:
|
Pharmaceutical ethics.
|
| Subject
|
:
|
Race-- Social aspects.
|
| Dewey Classification
|
:
|
174.2
|
| LC Classification
|
:
|
RS100.5.J64 2019
|
| |